Aim: To investigate whether methodological aspects may influence the performance of MRI-radiomic models to predict response to neoadjuvant treatment (NAT) in breast cancer (BC) patients. Materials and methods: We conducted a systematic review until March 2023. A random-effects meta-analysis was performed to combine the area under the receiver operating characteristic curve (AUC) values. Publication bias was assessed using Egger’s test and heterogeneity was estimated by I2. A meta-regression was conducted to investigate the impact of various factors, including scanner, features’ number/transformation/type, pixel/voxel scaling, etc. Results: Forty-two studies were included. The summary AUC was 0.77 (95% CI: 0.74–0.81). Substantial heterogeneity was observed (I2 = 81%) with no publication bias (p = 0.35). Radiomic model accuracy was influenced by the scanner vendor, with lower AUCs in studies using mixed scanner vendors (AUC; 95% CI: 0.70; 0.61–0.78) compared to studies including images obtained from the same scanner (AUC (95% CI): 0.83 (0.77–0.88), 0.74 (0.67–0.82), 0.83 (0.78–0.89) for three different vendors; vendors 1, 2, and 3, respectively; p-value = 0.03 for comparison with vendor 1). Feature type also seemed to have an impact on the AUC, with higher prediction accuracy observed for studies using 3D than 2D/2.5D images (AUC; 95% CI: 0.81; 0.78–0.85 and 0.73; 0.65–0.81, respectively, p-value = 0.03). Non-significant between-study heterogeneity was observed in the studies including 3D images (I2 = 33%) and Vendor 1 scanners (I2 = 40%). Conclusion: MRI-radiomics has emerged as a potential method for predicting the response to NAT in BC patients, showing promising outcomes. Nevertheless, it is important to acknowledge the diversity among the methodological choices applied. Further investigations should prioritize achieving standardized protocols, and enhancing methodological rigor in MRI-radiomics. Key Points: Question Do methodological aspects influence the performance of MRI-radiomic models in predicting response to NAT in BC patients? Findings Radiomic model accuracy was influenced by the scanner vendor and feature type. Clinical relevance Methodological discrepancies affect the performance of MRI-radiomic models. Developing standardized protocols and enhancing methodological rigor in these studies should be prioritized.

Methodological issues in radiomics: impact on accuracy of MRI for predicting response to neoadjuvant chemotherapy in breast cancer

Scalco, Elisa;Rizzo, Giovanna;
2024

Abstract

Aim: To investigate whether methodological aspects may influence the performance of MRI-radiomic models to predict response to neoadjuvant treatment (NAT) in breast cancer (BC) patients. Materials and methods: We conducted a systematic review until March 2023. A random-effects meta-analysis was performed to combine the area under the receiver operating characteristic curve (AUC) values. Publication bias was assessed using Egger’s test and heterogeneity was estimated by I2. A meta-regression was conducted to investigate the impact of various factors, including scanner, features’ number/transformation/type, pixel/voxel scaling, etc. Results: Forty-two studies were included. The summary AUC was 0.77 (95% CI: 0.74–0.81). Substantial heterogeneity was observed (I2 = 81%) with no publication bias (p = 0.35). Radiomic model accuracy was influenced by the scanner vendor, with lower AUCs in studies using mixed scanner vendors (AUC; 95% CI: 0.70; 0.61–0.78) compared to studies including images obtained from the same scanner (AUC (95% CI): 0.83 (0.77–0.88), 0.74 (0.67–0.82), 0.83 (0.78–0.89) for three different vendors; vendors 1, 2, and 3, respectively; p-value = 0.03 for comparison with vendor 1). Feature type also seemed to have an impact on the AUC, with higher prediction accuracy observed for studies using 3D than 2D/2.5D images (AUC; 95% CI: 0.81; 0.78–0.85 and 0.73; 0.65–0.81, respectively, p-value = 0.03). Non-significant between-study heterogeneity was observed in the studies including 3D images (I2 = 33%) and Vendor 1 scanners (I2 = 40%). Conclusion: MRI-radiomics has emerged as a potential method for predicting the response to NAT in BC patients, showing promising outcomes. Nevertheless, it is important to acknowledge the diversity among the methodological choices applied. Further investigations should prioritize achieving standardized protocols, and enhancing methodological rigor in MRI-radiomics. Key Points: Question Do methodological aspects influence the performance of MRI-radiomic models in predicting response to NAT in BC patients? Findings Radiomic model accuracy was influenced by the scanner vendor and feature type. Clinical relevance Methodological discrepancies affect the performance of MRI-radiomic models. Developing standardized protocols and enhancing methodological rigor in these studies should be prioritized.
2024
Istituto di Tecnologie Biomediche - ITB
Istituto di Sistemi e Tecnologie Industriali Intelligenti per il Manifatturiero Avanzato - STIIMA (ex ITIA)
Breast cancer
MRI
Neoadjuvant chemotherapy treatment
Pathological complete response
Radiomics
File in questo prodotto:
File Dimensione Formato  
Netti et al. - 2024 - EuropRad.pdf

solo utenti autorizzati

Tipologia: Versione Editoriale (PDF)
Licenza: NON PUBBLICO - Accesso privato/ristretto
Dimensione 1.25 MB
Formato Adobe PDF
1.25 MB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/20.500.14243/524352
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 2
  • ???jsp.display-item.citation.isi??? 0
social impact